Are associations between infection and coronary disease causal or due to confounding?

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 376-377

  Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TITER; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; EDITORIAL; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL;

CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; COUGH; HUMANS; INFECTION; RISK FACTORS;

EID: 0033106430     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00019-4     Document Type: Editorial

References (23)

1. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet. 1997;350:430-436.
3. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
4. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. NEJM. 1997;336:973-979.
5. Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998:351:88-92.
6. Ridker PM. Inflammation, infection, and cardiovascular risk: How good is the clinical evidence? Circulation. 1998;97:1671-1674.
7. Haider AW, Larson MG, O'Donnell CJ, et al. The association of chronic cough with the risk of myocardial infarction. The Framingham heart study. Am J Med. 1999;106:279-284.
8. Meier CR, Jick SS, Derby LE, et al. Acute respiratory tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467-1471.
9. Saikku P, Leinonen M, Tendanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med. 1992; 116:273-278.
10. Miettinen H, Lehto S, Saikku P, et al. Association of Chlamydia pneumoniae and acute coronary heart disease in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J. 1996;17:682-688.
11. Ridker PM, Kundsin RB, Stampfer MJ, et al. A prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999. In press.
12. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation. 1998;98:1286-1290.
13. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: Negative results from a large, prospective study. BMJ. 1997;315:1199-1201.
14. Whincup PH, Mendall MA, Perry IJ, et al. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle-aged men. Heart. 1996;75:568-572.
15. Strandberg TE, Tilvis RS, Vuoristo M, et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular disease in a general elderly population. BMJ. 1997;314:1317-1318.
16. Folsom AR, Nieto FJ, Sorlie P, et al. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation. 1998;98:845-850.
17. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796-2799.
18. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
19. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidimiol. 1996;144:537-547.
20. Haverkate F, Thompson SG, Pyke SDM, et al, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
21. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-1127.
22. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-733.
23. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-2011.